Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors [Phase 1]
This clinical trial update reports on a Phase 1 study evaluating the combination of nilotinib and paclitaxel in adults with relapsed solid t…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s) [Phase 1]
This is a Phase 1 study evaluating the safety, tolerability, pharmacokinetics and preliminary clinical activity of RO7673396 in participants…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study of HDM2024 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating HDM2024 in participants with advanced solid tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CGT4859, an FGFR2/3 inhibitor, for intrahepatic cholangiocarcinoma, cholangiocarcinoma, and other advanced solid tumors; …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida
A Mayo Clinic-led clinical trial in Florida is evaluating cancer literacy and screening awareness to advance health equity for incarcerated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS) [Phase 1, Phase 2]
Basket trial update for IDX-1197 in HRR-mutated solid tumors (VASTUS) across Phase 1 and Phase 2, now completed.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors [Phase 2]
Ongoing Phase 2 master protocol trial evaluating Genetically Engineered T Cells targeting NY-ESO-1 and LAGE-1a in solid tumors; currently ac…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor [Phase 1]
Phase 1 study of IMA401 TCER in patients with recurrent or refractory solid tumors, evaluated alone or in combination with a checkpoint inhi…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA) [Phase 1]
Phase 1 dose-escalation and expansion study evaluating TROPIKANA, a TROP2-targeted CAR-NK cell therapy engineered with IL-15 and derived fro…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating TGW101 in adults with advanced solid tumors is recruiting to assess safety, tolerability, pharmacokinetics, and p…
-
CLINICAL_TRIALS other · 2026-04-16Clinical Trial Update: A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
OTP-01, a dual PD-1/VEGFR2 antibody developed by Ottimo Pharma, is being studied in Phase 1/2 for advanced solid tumors with recruitment ong…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours [Phase 1]
Phase I clinical study of HLX3902 in metastatic castration-resistant prostate cancer and other advanced/metastatic solid tumors; the trial s…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating KIVU-107 in participants with locally advanced or metastatic solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function [Phase 1]
This Phase 1 trial update reports a study comparing blood levels and safety of tazemetostat in participants with advanced cancer and hepatic…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients [Phase 1]
Phase 1 trial evaluating 18F-Fluoroazomycin Arabinoside PET-CT for diagnosing solid tumors, including breast and colorectal cancers, with ac…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and tolerability of TNG908 in MTAP-deleted solid tumors has been terminated. The sponsor is Tango Therapeu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase 1 Study of IM-1021 in Participants With Advanced Cancer [Phase 1]
A Phase 1 study evaluating IM-1021 in adults with advanced solid tumors or hematologic malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
A Phase 1 study evaluating ATG-022 in patients with advanced or metastatic solid tumors is currently recruiting. The trial is sponsored by A…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study of INCB123667 in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 study of INCB123667 in advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer [Phase 1]
This Phase 1 trial assesses BI 765179 alone and with Ezabenlimab in advanced solid tumors, and BI 765179 with Pembrolizumab in advanced head…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine [Phase 2]
A Phase 2 study to assess long-term brigimadlin treatment in people with solid tumors who previously participated in a brigimadlin trial; th…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating GT101 injection for metastatic or recurrent solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating INCA036873 in participants with advanced solid tumors and hematologic malignancies is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
National Cancer Institute-funded clinical trial has completed, evaluating machine learning analysis of facial imaging, voice, and spoken lan…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria [Phase 1]
Phase I pharmacokinetic study of pazopanib in frail elderly patients (SIOG criteria) was terminated; the trial investigated pazopanib in div…